Skip to content
Unrated Medical device recall · FDA · Published April 3, 2026

Elekta Fletcher CT/MR Shielded Applicator Set Recall: Risk of IU Tube Detachment

Elek: Recall of Fletcher CT/MR Shielded Applicator Set due to potential IU tube detachment after use. Affected units may cause retained tissue in patients.

🇺🇸 FDA recall #Z-2710-2026Medical deviceElekta ›
Take action

Contact the company

Recalling firmElekta, Inc.400 Perimeter Center Ter NE Ste 50 · Atlanta, GA 30346-1227
✎ GovInfoNow plain-language explainer

Elekta is recalling its Fletcher CT/MR Shielded Applicator Set for gynecological brachytherapy. The recall is due to a risk that the intrauterine tube tip may detach and remain inside a patient, potentially causing retained tissue. Read more at govinfonow.com/recall/49546-elekta-fletcher-ct-mr-shielded-applicator-set-recall-risk-of.

Source Summary by GovInfoNow · govinfonow.com/recall/49546-elekta-fletcher-ct-mr-shielded-applicator-set-recall-risk-of · Updated August 18, 2026 · FDA enforcement record: FDA #Z-2710-2026

Cite this page

“Elekta Fletcher CT/MR Shielded Applicator Set Recall: Risk of IU Tube Detachment.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/49546-elekta-fletcher-ct-mr-shielded-applicator-set-recall-risk-of. Based on FDA recall #Z-2710-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2710-2026%22&limit=1).

The FDA announced on April 3, 2026, that Elekta, Inc. is recalling the Fletcher CT/MR Shielded Applicator Set due to safety concerns regarding the detachment of the intrauterine tube tip. The agency issued recall number Z-2710-2026 for the Class II device.

How to tell if you have it

  • Brand: Elekta
  • Product Name: Intracavitary Remote Afterloading Applicator
  • Lot Code: 08717213024205

The hazard

The recall addresses the risk that the tip of the intrauterine tube may detach and remain within a patient during use. The FDA stated these are safety concerns regarding the device's integrity.

Context

GovInfoNow's records show Elekta, Inc. has issued 39 other recalls since June 19, 2017. Recent similar recalls include the Leksell Gamma Knife Perfexion and Icon models (Feb. 18, 2026) and the Leksell Vantage Arc System (March 19, 2026). Other recent recalls of similar products include the Medtronic GUNDRY Cannula Recall (April 21, 2026), the Medtronic Bio-Medicus Adult Cannula Kit Recall (May 25, 2026), and the Medline Urethral Catheter Tray Recall (May 4, 2026).

How to tell if you have this one

The product is labeled 'Fletcher CT/MR Shielded Applicator Set' for gynecological brachytherapy. It was sold with lot code 08717213024205.

  • Brand
    Elekta
  • Category
    Medical device
FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    Worldwide - U.S. Nationwide distribution including in the states of AR, AZ, CA, CO, CT, DC, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, MI, MO, MS, NC, ND, NE, NJ, NV, NY, OH, OK, OR, PA, SC, SD, TX, UT, VA, WI, and WV. The countries of Argentina, Australia, Austria, Bahrain, Bangladesh, Belgium, Bolivia, Botswana, Brazil, Burkina Faso, Cambodia, Canada, Chile, China, Colombia, Croatia, Cyprus, Czech Republic, Denmark, Ecuador, Egypt, Finland, France, Georgia, Germany, Greece, Guatemala, Honduras, Hong Kong, Hungary, India, Indonesia, Iran (Islam Republic of), Iraq, Ireland, Italy, Japan, Kazakhstan, Kenya, Korea (Republic of), Kosovo, Malaysia, Mexico, Morocco, Netherlands, New Zealand, Norway, Pakistan, Panama, Peru, Philippines, Poland, Portugal, Romania, Russian Federation, Rwanda, Saudi Arabia, Singapore, Slovakia, South Africa, Spain, Swaziland, Sweden, Switzerland, Taiwan, Thailand, Togo, Turkey, Ukraine, United Arab Emirates, United Kingdom, Venezuela, Viet Nam, and Zambia.
Recall numberProduct, codes & lotsQuantity
Z-2710-2026Brand Name: Fletcher CT/MR Shielded Applicator Set Product Name: Intracavitary Remote Afterloading Applicator Product Description: The Fletcher CT/MR Shielded Applicator Set is intended for gynecological brachytherapy treatment of the cervix and endometrium.; Lot Code: 087172130242051
Z-2711-2026Brand Name: Brachytherapy Applicator Product Name: Advanced Gynecological Applicator Product Description: The intended use of the Advanced Gynecological Applicator is intracavitary brachytherapy for cancer treatment of the cervix and endometrium. Optional needles can be placed for interstitial brachytherapy.; Lot Code: 08717213055001, 08717213055018, 08717213055025, 08717213055049, 08717213055056, 08717213055063, 08717213055087, 08717213055094, 08717213055100, 08717213055117, 08717213055131586
Z-2712-2026Brand Name: Geneva Product Name: Brachytherapy Applicator Product Description: The device is intended for intracavitary brachytherapy for cancer treatment of the cervix and the endometrium. Optional needles can be placed for interstitial therapy.; Lot Code: 08717213056039, 08717213056053, 08717213056077, 08717213056091, 08717213056398, 08717213056411, 08717213056435, 08717213056459, 08717213056473, 08717213056497, 08717213056510,08717213056534, 08717213056558, 08717213056572, 08717213056596, 08717213056619, 08717213056633, 087172130566571317
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for the product name 'Fletcher CT/MR Shielded Applicator Set' and lot code 08717213024205.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 35 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: nationwideWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: named in the noticeNDMinnesota: nationwideMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: nationwideRIMassachusetts: named in the noticeMAOregon: named in the noticeORNevada: named in the noticeNVWyoming: nationwideWYSouth Dakota: named in the noticeSDIowa: named in the noticeIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: named in the noticeCTCalifornia: named in the noticeCAUtah: named in the noticeUTColorado: named in the noticeCONebraska: named in the noticeNEMissouri: named in the noticeMOKentucky: named in the noticeKYWest Virginia: named in the noticeWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: nationwideDEArizona: named in the noticeAZNew Mexico: nationwideNMKansas: named in the noticeKSArkansas: named in the noticeARTennessee: nationwideTNNorth Carolina: named in the noticeNCSouth Carolina: named in the noticeSCDistrict of Columbia: named in the noticeDCOklahoma: named in the noticeOKLouisiana: named in the noticeLAMississippi: named in the noticeMSAlabama: nationwideALGeorgia: named in the noticeGAHawaii: nationwideHITexas: named in the noticeTXFlorida: named in the noticeFL

FDA distribution: “Worldwide - U.S. Nationwide distribution including in the states of AR, AZ, CA, CO, CT, DC, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, MI, MO, MS, NC, ND, NE, NJ, NV, NY, OH, OK, OR, PA, SC, SD, TX, UT, VA, WI, and WV. The countries of…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Mississippi, Missouri, Nebraska, Nevada, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, South Dakota, Texas, Utah, Virginia, West Virginia, Wisconsin.

Recall timeline

FDA published this recall 3 months after the firm started it.

1. Firm started the recall: Apr 3, 202612. FDA classified it Class II: Jul 9, 202623. Published in FDA’s Enforcement Report: Jul 15, 202632026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is there a risk of serious injury?

The recall mentions potential retained tissue, but the official notice does not describe a risk of serious injury or death.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2710-2026 (April 3, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2710-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA